DK0664708T3 - Metode til behandling af cancer ved kombinationsbehandling med 2'-halogenmethylidenderivater og et S-fase- eller M-fase-spe - Google Patents

Metode til behandling af cancer ved kombinationsbehandling med 2'-halogenmethylidenderivater og et S-fase- eller M-fase-spe

Info

Publication number
DK0664708T3
DK0664708T3 DK93907581T DK93907581T DK0664708T3 DK 0664708 T3 DK0664708 T3 DK 0664708T3 DK 93907581 T DK93907581 T DK 93907581T DK 93907581 T DK93907581 T DK 93907581T DK 0664708 T3 DK0664708 T3 DK 0664708T3
Authority
DK
Denmark
Prior art keywords
phase
spec
combination therapy
treating cancer
halomethylidene
Prior art date
Application number
DK93907581T
Other languages
Danish (da)
English (en)
Inventor
Sai P Sunkara
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0664708T3 publication Critical patent/DK0664708T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK93907581T 1992-04-10 1993-03-15 Metode til behandling af cancer ved kombinationsbehandling med 2'-halogenmethylidenderivater og et S-fase- eller M-fase-spe DK0664708T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86639992A 1992-04-10 1992-04-10
PCT/US1993/002490 WO1993020825A1 (en) 1992-04-10 1993-03-15 Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent

Publications (1)

Publication Number Publication Date
DK0664708T3 true DK0664708T3 (da) 1998-11-02

Family

ID=25347526

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93907581T DK0664708T3 (da) 1992-04-10 1993-03-15 Metode til behandling af cancer ved kombinationsbehandling med 2'-halogenmethylidenderivater og et S-fase- eller M-fase-spe

Country Status (17)

Country Link
US (2) US20040102461A1 (es)
EP (1) EP0664708B1 (es)
JP (1) JP3713668B2 (es)
KR (1) KR100258668B1 (es)
AT (1) ATE170077T1 (es)
AU (1) AU667527B2 (es)
CA (1) CA2117891C (es)
DE (1) DE69320646T2 (es)
DK (1) DK0664708T3 (es)
ES (1) ES2123642T3 (es)
HU (1) HU219476B (es)
IL (1) IL105329A (es)
MX (1) MX9302038A (es)
NZ (1) NZ251211A (es)
TW (1) TW362971B (es)
WO (1) WO1993020825A1 (es)
ZA (1) ZA932455B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996001638A1 (en) * 1994-07-11 1996-01-25 Hoechst Marion Roussel, Inc. Method of treating a neoplastic disease state by conjunctive therapy with 2'-fluoromethylidene derivatives and radiation or chemotherapy
WO1996001834A1 (fr) * 1994-07-12 1996-01-25 Yamasa Corporation 2'-desoxy-2'-(methylidene substitue ou non substitue)-4'-thionucleoside
US7220737B1 (en) 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
ES2224430T3 (es) 1997-09-04 2005-03-01 Novoneuron Inc Noribogaina en el tratamiento del dolor y de la toxicomania.
US6544962B1 (en) 2000-11-02 2003-04-08 Matrix Pharmaceutical, Inc. Methods for treating cellular proliferative disorders
US20040002476A1 (en) * 2002-02-14 2004-01-01 Stuyver Lieven J. Modified fluorinated nucleoside analogues
WO2004042081A1 (de) * 2002-11-04 2004-05-21 Charité-Universitätsme Dizin Berlin Spezifische haplotypen des mdr1-gens und deren anwendung in der diagnose und therapie
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
JP6049615B2 (ja) 2010-07-23 2016-12-21 デマークス・インコーポレイテッドＤｅｍｅｒｘ，Ｉｎｃ． ノリボガイン組成物
EP2481740B1 (en) 2011-01-26 2015-11-04 DemeRx, Inc. Methods and compositions for preparing noribogaine from voacangine
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
WO2013085922A1 (en) 2011-12-09 2013-06-13 Demerx, Inc. Phosphate esters of noribogaine
AP2014007796A0 (en) 2011-12-22 2014-07-31 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
US8877921B2 (en) 2012-01-25 2014-11-04 Demerx, Inc. Synthetic voacangine
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
JP2016508979A (ja) 2012-12-20 2016-03-24 デメレックス， インコーポレイテッド 置換ノルイボガイン
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
US9550789B2 (en) 2014-06-18 2017-01-24 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them

Also Published As

Publication number Publication date
HU9402914D0 (en) 1995-01-30
AU667527B2 (en) 1996-03-28
US20040102461A1 (en) 2004-05-27
ES2123642T3 (es) 1999-01-16
CA2117891C (en) 1998-07-07
IL105329A (en) 1998-06-15
DE69320646T2 (de) 1999-01-14
EP0664708B1 (en) 1998-08-26
CA2117891A1 (en) 1993-10-28
EP0664708A1 (en) 1995-08-02
HU219476B (hu) 2001-04-28
ZA932455B (en) 1993-10-20
TW362971B (en) 1999-07-01
IL105329A0 (en) 1993-08-18
ATE170077T1 (de) 1998-09-15
HUT71224A (en) 1995-11-28
WO1993020825A1 (en) 1993-10-28
AU3813193A (en) 1993-11-18
KR950700749A (ko) 1995-02-20
US20050032738A1 (en) 2005-02-10
EP0664708A4 (en) 1995-04-24
JPH07505653A (ja) 1995-06-22
KR100258668B1 (ko) 2000-07-01
NZ251211A (en) 1997-05-26
DE69320646D1 (de) 1998-10-01
MX9302038A (es) 1993-10-01
JP3713668B2 (ja) 2005-11-09

Similar Documents

Publication Publication Date Title
DK0664708T3 (da) Metode til behandling af cancer ved kombinationsbehandling med 2'-halogenmethylidenderivater og et S-fase- eller M-fase-spe
BR9306619A (pt) Glicosídeos esteroidais para o tratamento da hipercolesterolemia
WO1999015167A3 (en) Use of citrus limonoids and flavonoids as well as tocotrienols for the treatment of cancer
DK0502092T3 (da) Oralt præparat til behandling af inflammatoriske tarmsygdomme
IS4073A (is) Nýtt fjölvirknislyf gegn aukningu mótstöðu
DK0513702T3 (da) Melatoninderivater til anvendelse til behandling af søvnlidelser og til præ-anæstetisk medicinering
DK95091D0 (da) Anvendelse af acetyl-d-carnitin ved terapeutisk behandling af glaucoma
DE69629570D1 (de) 3'utr des menschliches prohibitin-gens
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
NO931413D0 (no) Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer
ITMI910456A0 (it) Composizione farmaceutica per il trattamento della cataratta
DK0986393T3 (da) Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer
DK0588873T3 (da) Behandling af levercancer
NO943795L (no) Metode for behandling av kreft ved konjunktiv terapi med 2'-halomethylidenderivater og et S-fase eller M-fase-spesifikt antineoplastisk middel
DK0572549T3 (da) Behandling af ikke-småcellet lungecarcinom
FI952805A0 (fi) Asetosalisyylihappoa sisältävä transdermaalinen vapautumisjärjestelmä antitromboottiseen terapiaan ja syövän ennaltaehkäisyyn
IT1243734B (it) Composizione per uso terapeutico e/o cosmetico per il trattamento di disturbi circolatori e per trattamenti di medicina estetica
DE3374066D1 (en) N-acyl derivatives of peptides, their manufacture and use in combating diseases and means therefor
BR9708037A (pt) Método para o tratamento de abuso de substância
NO952194D0 (no) Spirofuranonderivater og deres anvendelse ved behandling av neurodegenerative sykdommer
DK228289A (da) Anvendelse af gonadoliberinderivater ved fremstilling af laegemidler til behandling af svulster
FR2699174B1 (fr) Dérivés de 3-(quinoléin-6-yl-méthyl)-4H-imidazol-4-one, leur préparation et leur application en thérapeutique.
AUPM496094A0 (en) Improved orthotic device for the treatment of patella tendon disorders incorporating therapeutic pulsed electromagnetic field therapy
GB9024181D0 (en) Pharmaceutical compositions and methods for the treatment of malignancy
DK0774964T3 (da) Kontrolleret lokal tilförsel af kemoterapeutiske midler til behandling af faste tumorer